Hormone Test Predicts Ovarian Function After Chemotherapy For Breast Cancer
6/06/2011
A test that shows how many eggs a woman has in her ovaries may help young women with breast cancer know what their reproductive function will be after chemotherapy, a new study finds. The results will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston...
Ovarian Cancer Screening Does Not Cut Disease-Related Mortality
6/06/2011
New data demonstrates that average-risk women who are screened for ovarian cancer using serum cancer antigen 125 (CA-125) and transvaginal ultrasound do not have a lower ovarian cancer mortality rate than women who receive usual care...
Combination Antibody Therapy Shows Promise In Metastatic Melanoma
6/06/2011
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators...
Ovarian Cancer Screening Does Not Cut Disease-Related Mortality
6/05/2011
New data demonstrate that average-risk women who are screened for ovarian cancer using serum cancer antigen 125 (CA-125) and transvaginal ultrasound do not have a lower ovarian cancer mortality rate than women who receive usual care...
Increased Diabetes Risk From Hormone Deprivation Therapy For Prostate Cancer
6/05/2011
Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cancer. The results of this new study on the second-most common cancer in men were presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston...
Promising Use For Thyroid Cancer Gene
6/05/2011
A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found. The findings are being presented by Mayo Clinic researcher Honey Reddi, Ph.D., at the Endocrine Society meeting in Boston. Dr...
Adding Radiation Therapy Benefits Breast Cancer Surgery Patients
6/05/2011
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study found. The results will be presented Monday, June 6 at the annual meeting of the American Society of Clinical Oncology...
Increased Rate Of Mortality In Obese Breast Cancer Survivors
6/05/2011
Women with a healthy body weight before and after diagnosis of breast cancer are more likely to survive the disease long term, a new study finds. The results were presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston. The study, conducted in nearly 4,000 breast cancer survivors, found that obesity is strongly linked to death due to breast cancer...
Drug That Reduces Breast Cancer In High-Risk Women
6/05/2011
A major announcement at the American Society of Clinical Oncology annual meeting: The drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women. It is the result of an international, randomized double-blind phase III clinical trial in which University at Buffalo researchers and hundreds of Western New York women played a critical role...
Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy
6/05/2011
A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO)...